Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
103 studies found for:    Open Studies | "Carcinoma, Ductal, Breast"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)
Condition: Ductal Carcinoma In Situ
Interventions: Drug: Carboplatin i.d. Days 1 & 15;   Drug: Carboplatin i.d. Day 1; Normal Saline i.d. Day 15;   Drug: Normal Saline
2 Recruiting A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ
Condition: Ductal Carcinoma in Situ
Intervention: Dietary Supplement: Black cohosh
3 Recruiting A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
Condition: Ductal Carcinoma in Situ
Intervention: Drug: Polyphenon E
4 Recruiting A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma
Condition: Pancreatic Ductal Adenocarcinoma
Interventions: Behavioral: The risk assessment questionnaire;   Other: Blood specimens;   Other: tumor tissue samples will be requested
5 Recruiting Study of Gemcitabine+Platinium Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (BEVABEL)
Condition: Collecting Duct Carcinoma (Kidney)
Intervention: Drug: Bevacizumab
6 Recruiting Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: Momelotinib;   Drug: Placebo to match momelotinib;   Drug: Nab-paclitaxel;   Drug: Gemcitabine
7 Unknown  Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma
Condition: Non-curative Resectable Bile Duct Carcinoma
Intervention: Drug: Temoporfin
8 Unknown  Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast Carcinoma
Condition: Newly Diagnosed Operative Invasive Ductal Breast Carcinoma Stage I-II
Intervention: Dietary Supplement: Vitamin D
9 Recruiting Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma
Condition: Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: MMB;   Drug: Capecitabine;   Drug: Oxaliplatin
10 Recruiting Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Conditions: Carcinoma, Intraductal, Noninfiltrating;   DCIS;   Ductal Carcinoma In Situ
Interventions: Drug: Chloroquine Standard Dose (500mg/week);   Drug: Chloroquine Low Dose (250mg/week);   Procedure: Breast Biopsy
11 Not yet recruiting Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer
Conditions: Ductal Breast Carcinoma in Situ;   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   Invasive Ductal Breast Carcinoma;   Invasive Ductal Breast Carcinoma With Predominant Intraductal Component;   Lobular Breast Carcinoma in Situ;   Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate;   Mucinous Ductal Breast Carcinoma;   Papillary Ductal Breast Carcinoma;   Progesterone Receptor-positive Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Tubular Ductal Breast Carcinoma
Interventions: Radiation: accelerated partial breast irradiation;   Radiation: intensity-modulated radiation therapy;   Radiation: image-guided radiation therapy;   Procedure: therapeutic conventional surgery;   Other: questionnaire administration;   Other: laboratory biomarker analysis
12 Recruiting Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer
Conditions: Breast Cancer;   Ductal Carcinoma in Situ
Intervention: Drug: Intranasal Oxytocin
13 Recruiting Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
Condition: Carcinoma, Ductal, Breast
Interventions: Procedure: Biopsy before and after three weeks of study treatment;   Drug: Paclitaxel;   Drug: lapatinib;   Drug: trastuzumab
14 Recruiting MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Condition: Ductal Breast Carcinoma In Situ
Interventions: Procedure: Magnetic Resonance Imaging;   Procedure: Therapeutic Conventional Surgery;   Procedure: Therapeutic Surgical Procedure;   Radiation: Radiation Therapy;   Drug: Endocrine Therapy;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis;   Other: Cytology Specimen Collection Procedure
15 Recruiting Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml®
Conditions: Breast Cancer;   Ductal Carcinoma in Situ
Intervention: Device: Mammosite ML
16 Recruiting Plasma Biomarkers P-DAC, V1
Condition: Pancreatic Ductal Adenocarcinoma
Intervention:
17 Recruiting Intraoperative Imaging of Breast Cancer With Indocyanine Green
Conditions: Invasive Ductal Carcinoma;   Invasive Lobular Carcinoma;   Ductal Carcinoma
Intervention: Drug: Indocyanine Green
18 Recruiting Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer
Condition: Pancreatic Ductal Adenocarcinoma
Intervention: Drug: PTP-01
19 Recruiting Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
Conditions: Invasive Ductal Carcinoma;   Ductal Carcinoma in Situ
Intervention: Radiation: Intra-operative Radiation Therapy - IORT
20 Recruiting A Phase II Study of Neoadjuvant FOLFIRINOX
Condition: Resectable Pancreatic Ductal Adenocarcinoma
Intervention: Drug: FOLFIRINOX

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years